The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

PubChem20200     1H-indole-2-carboxamide

Synonyms: SureCN118686, AG-E-16460, ALBB-007757, AK-47015, KB-12399, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Indole, 2-carboxamide-

  • Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide [1].
 

High impact information on Indole, 2-carboxamide-

  • Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of exceptionally potent indolyl aryl sulfones (IASs) characterized by the presence of either a pyrrolidyn-2-one nucleus at the indole-2-carboxamide or some substituents at the indole-2-carbohydrazide [2].
  • Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidation [3].
  • 1. Experiments were conducted to determine whether or not the effect of (+)-fenfluramine (3.0 mg kg-1, i.p.) on food intake can be antagonized by the selective cholecystokinin receptor antagonist MK-239 (formerly L364,718; (3S(-)-N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1-H-1,4-benzodiazepin++ +-3-yl)-1H- indole-2-carboxamide) [4].
  • CI-949 [5-methyl-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H- indole-2- carboxamide, L-arginine salt] inhibits human neutrophil activation in response to stimuli which promote calcium mobilization or calcium influx [5].
  • A novel series of indole-2-carboxamide derivatives was prepared and identified as NR2B selective NMDA receptor antagonists [6].
 

Biological context of Indole, 2-carboxamide-

References

  1. Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide. De Martino, G., La Regina, G., Ragno, R., Coluccia, A., Bergamini, A., Ciaprini, C., Sinistro, A., Maga, G., Crespan, E., Artico, M., Silvestri, R. Antivir. Chem. Chemother. (2006) [Pubmed]
  2. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. Ragno, R., Coluccia, A., La Regina, G., De Martino, G., Piscitelli, F., Lavecchia, A., Novellino, E., Bergamini, A., Ciaprini, C., Sinistro, A., Maga, G., Crespan, E., Artico, M., Silvestri, R. J. Med. Chem. (2006) [Pubmed]
  3. Novel indole-2-carboxamide and cycloalkeno[1,2-b]indole derivatives. Structure-activity relationships for high inhibition of human LDL peroxidation. Kuehm-Caubere, C., Caubere, P., Jamart-Gregoire, B., Negre-Salvayre, A., Bonnefont-Rousselot, D., Bizot-Espiard, J.G., Pfeiffer, B., Caignard, D.H., Guardiola-Lemaitre, B., Renard, P. J. Med. Chem. (1997) [Pubmed]
  4. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Cooper, S.J., Dourish, C.T., Barber, D.J. Br. J. Pharmacol. (1990) [Pubmed]
  5. Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949: mechanism of inhibitory activity. Wright, C.D., Kuipers, P.J., Hoffman, M.D., Thueson, D.O., Conroy, M.C. Biochem. Biophys. Res. Commun. (1990) [Pubmed]
  6. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Borza, I., Kolok, S., Gere, A., Agai-Csongor, E., Agai, B., Tárkányi, G., Horváth, C., Barta-Szalai, G., Bozó, E., Kiss, C., Bielik, A., Nagy, J., Farkas, S., Domány, G. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  7. Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism? Nagy, J. IDrugs : the investigational drugs journal. (2004) [Pubmed]
 
WikiGenes - Universities